Life Sciences Ontario (LSO) is pleased to welcome Rebecca Yu, Head of JLABS @ Toronto at Johnson & Johnson Innovation, to its Board of Directors. “With her expertise in health technology assessment, policy, and the global pharmaceutical industry – along with a mindset geared toward innovation, Ms. Yu is a…
Life Sciences Ontario
Company completing Phase 1 human clinical trial of drug to prevent dermal scarring VANCOUVER (February 16, 2016) — Accel-Rx Health Sciences Accelerator (Accel-Rx), a Centre of Excellence for the Commercialization of Research (CECR), and its partner BDC Capital today announced their second joint investment in ScarX Therapeutics, a Canadian biotechnology…
On February 24, TO Health!’s inaugural Top 5 in 10 Summit will connect business leaders, academics, elected officials and policy makers from across the Toronto region. TORONTO, Feb. 2, 2016 /CNW/ –TO Health! today announced its evolution and strategy to raise the profile of the Toronto Region Human Health and Sciences (HHS)…
New centre for advanced therapeutic cell technologies will accelerate development andaccessibility of cell manufacturing technologies Chalfont St. Giles, UK and Toronto, Canada – 13 January 2016 – GE Healthcare, the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), and the Centre for Commercialization of Regenerative Medicine (CCRM) are building…
January 5, 2016 – Kitchener, Ontario – Global Affairs Canada The Honourable Chrystia Freeland, Minister of International Trade, and the Honourable Bardish Chagger, Minister of Small Business and Tourism, today announced CanExport, a new program that will provide $50 million to help Canadian small and medium-sized enterprises take advantage of global…